Leading TV streaming company Roku (ROKU) is enjoying a successful debut on the Nasdaq, so far. Tha stock opened higher than its offer price and ended the day with a breathtaking gain of 66%.The initial public offering is garnering a lot of attention from investors and non-investors alike as one of the companies that led the […]
Biotech Celcuity (CELC) proved investors are still happy to gamble on new drug discovery as shares soared nearly 50% on its first day of trading on the Nasdaq.The initial public offering also raised more than expected.Here’s what you need to know.1. Celcuity Raised $22.8 Million and Shares SoaredCelcuity priced a more-than-expected 2.4 million shares at […]
The initial public offering market is back from its summer break and the new issues calendar is filling up.
A big chemicals initial public offering couldn’t quite live up to the performance the smaller biotech IPOs have enjoyed recently.Venator Materials (VNTR), a division of chemical giant Huntsman, priced at the low end of its range, but saw some gains on the NYSE in midday trading.Here’s what you need to know.1. The IPO Raised $454 […]
Major names in the market got bullish calls from research analysts.Here’s what’s you need to know as an investor.Netflix Is Pricey, but Don’t Consider ShortingNetflix (NFLX) is enjoying a handful of $200 price targets and Buy rating reiterations this morning.International subscriber growth dwarfed domestic growth and the company anticipated turning a profit in the second […]
Biotech company Avenue Therapeutics was supposed to hit the market last week, but demand was clearly a problem. The company, which will trade on the Nasdaq under the symbol ATXI, is now day to day on when it will price its IPO.Avenue is focusing on developing intravenous delivery for tramadol, a synthetic opioid used to […]